 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: ABR-215062 | TV-5600
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Laquinimod is an experimental immunomodulator being investigated as an oral treatment for multiple sclerosis (MS) [2-5].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| In vivo studies have shown that laquinimod inhibits development and relapses of experimental autoimmune encephalomyelitis (EAE) and neuritis, which are used as animal models of MS [1,4,6]. In a mouse model of acute AEA, laquinimod showed a dose-dependent inhibition of clinical disease score, reaching 100% inhibition at 5(mg/kg)/day [4]. |